Oxford Biomedica PLC
A global CDMO specializing in cell and gene therapy and viral vector manufacturing.
OXB | IL
Overview
Corporate Details
- ISIN(s):
- GB00BDFBVT43
- LEI:
- 213800S1GVQNXQ15K851
- Country:
- United Kingdom
- Address:
- WINDRUSH COURT, OX4 6LT OXFORD
- Website:
- https://www.oxb.com/
- Sector:
- Manufacturing
Description
Oxford Biomedica (OXB) is a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. A pioneer in the field, the company has extensive experience in viral vectors, the enabling technology for many advanced therapies. OXB provides end-to-end services to pharmaceutical and biotechnology partners, supporting programs from preclinical development through to commercial launch. Its core expertise includes the development and GMP manufacturing of various vector types, including lentivirus, adeno-associated virus (AAV), and adenovirus. The company offers proprietary technologies like its LentiVector™ platform, the first commercially approved lentiviral system, and its inAAVate™ platform for AAV, in addition to tech-transfer capabilities.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-01-28 15:04 |
Holdings in Company
|
English | 40.2 KB | ||
| 2022-01-28 08:38 |
Retail offer by PrimaryBid
|
English | 22.2 KB | ||
| 2022-01-28 08:24 |
US Agreement and Proposed Placing of Shares
|
English | 221.3 KB | ||
| 2022-01-17 08:00 |
John Dawson to retire from Oxford Biomedica
|
English | 9.7 KB | ||
| 2022-01-05 08:00 |
Oxford Biomedica Agreement with Cabaletta Bio
|
English | 9.8 KB | ||
| 2022-01-04 12:07 |
Block listing Return
|
English | 20.5 KB | ||
| 2022-01-04 11:32 |
Total Voting Rights
|
English | 9.1 KB | ||
| 2022-01-04 08:00 |
John Dawson awarded CBE in New Year Honours List
|
English | 8.7 KB | ||
| 2021-12-14 08:00 |
Board Appointment
|
English | 9.6 KB | ||
| 2021-12-13 08:00 |
Oxford Biomedica Updates Lentiviral Agreement
|
English | 11.3 KB | ||
| 2021-12-01 10:49 |
Total Voting Rights
|
English | 9.2 KB | ||
| 2021-11-01 11:08 |
Long Term Incentive Plan Option Grant
|
English | 19.6 KB | ||
| 2021-11-01 11:02 |
Total Voting Rights
|
English | 9.2 KB | ||
| 2021-10-19 08:00 |
Boehringer Ingelheim Exercises Option
|
English | 13.5 KB | ||
| 2021-10-01 10:51 |
Total Voting Rights
|
English | 9.2 KB |
Automate Your Workflow. Get a real-time feed of all Oxford Biomedica PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Oxford Biomedica PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Oxford Biomedica PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
